COM:VRTX
Vertex Pharmaceuticals Incorporated
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
vrtx.comcrunchbase
vertex-pharmaceuticalslinkedin
vertex-pharmaceuticalsfounding date
Jan 01, 1989ipo date
Jul 24, 1991
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients ...Show More